Omaveloxolone
CAS 1474034-05-3Small Molecule
Overview
Omaveloxolone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4303525).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Omaveloxolone expires 24 Apr 2033 and exclusivity 28 Feb 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide
- Canonical SMILES
- C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F
- InChIKey
- RJCWBNBKOKFWNY-IDPLTSGASA-N
Verified Supplier Partner
Do you supply Omaveloxolone? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.